Cowin Biotech released its performance for the first three quarters, with a net loss attributable to the parent company of 76.16 million yuan

According to the Zhitong Finance APP, Cowin Biotech disclosed its third-quarter report for 2025. The company achieved revenue of 140 million yuan in the first three quarters, a year-on-year increase of 42.01%; the net profit attributable to the parent company was a loss of 76.16 million yuan; the net profit excluding non-recurring gains and losses was a loss of 93.91 million yuan; basic earnings per share were -0.69 yuan